Cargando…

Lymphocyte integrins mediate entry and dysregulation of T cells by SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Huang, Mengwen, Pan, Xingchao, Wang, Xinling, Ren, Qingfei, Tong, Bei, Dong, Xianchi, Ge, Gaoxiang, Lu, Lu, Jiang, Shibo, Chen, Jianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969015/ https://www.ncbi.nlm.nih.gov/pubmed/36849525 http://dx.doi.org/10.1038/s41392-023-01348-0

Ejemplares similares

Integrin-dependence of Lymphocyte Entry into the Splenic White Pulp
por: Lo, Charles G., et al.
Publicado: (2003)

SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread
por: Wang, Xinling, et al.
Publicado: (2023)

Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
por: Wang, Xinling, et al.
Publicado: (2020)

RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
por: Wang, Xinling, et al.
Publicado: (2020)

An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen
por: Wang, Xinling, et al.
Publicado: (2023)

Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2
por: Liu, Jiamnin, et al.
Publicado: (2022)

A potential role for integrins in host cell entry by SARS-CoV-2
por: Sigrist, Christian JA, et al.
Publicado: (2020)

Integrin αvβ1 facilitates ACE2-mediated entry of SARS-CoV-2
por: Cai, Zeqiong, et al.
Publicado: (2023)

Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein
por: Sun, Zhiwu, et al.
Publicado: (2013)

A mutation that blocks integrin α(4)β(7) activation prevents adaptive immune-mediated colitis without increasing susceptibility to innate colitis
por: Zhang, Hailong, et al.
Publicado: (2020)

Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein
por: Chen, Yuliu, et al.
Publicado: (2022)

N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
por: Tian, Fang, et al.
Publicado: (2021)

SARS-CoV-2 Dysregulates Neutrophil Degranulation and Reduces Lymphocyte Counts
por: Muralidharan, Abenaya, et al.
Publicado: (2022)

Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection
por: Liu, Zezhong, et al.
Publicado: (2020)

Permeability Changes of Integrin-Containing Multivesicular Structures Triggered by Picornavirus Entry
por: Soonsawad, Pan, et al.
Publicado: (2014)

Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
por: Xia, Shuai, et al.
Publicado: (2014)

The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2
por: Krasemann, Susanne, et al.
Publicado: (2022)

Role of host factors in SARS-CoV-2 entry
por: Evans, John P., et al.
Publicado: (2021)

Integrin α4β7 switches its ligand specificity via distinct conformer-specific activation
por: Wang, ShiHui, et al.
Publicado: (2018)

An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane
por: Wang, Chao, et al.
Publicado: (2023)

Metabolic dysregulation impairs lymphocyte function during severe SARS-CoV-2 infection
por: Gurshaney, Sanjeev, et al.
Publicado: (2023)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

Protein- and Peptide-Based Virus Inactivators: Inactivating Viruses Before Their Entry Into Cells
por: Su, Xiaojie, et al.
Publicado: (2020)

The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
por: Xia, Shuai, et al.
Publicado: (2020)

Age-Associated Dysregulation of Integrin Function in Vascular Smooth Muscle
por: Ojha, Krishna Raj, et al.
Publicado: (2022)

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
por: He, Yuxian, et al.
Publicado: (2004)

How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17
por: Healy, Eamonn F.
Publicado: (2022)

Reovirus directly engages integrin to recruit clathrin for entry into host cells
por: Koehler, Melanie, et al.
Publicado: (2021)

Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
por: Pu, Jing, et al.
Publicado: (2019)

Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket
por: Yu, Fei, et al.
Publicado: (2013)

The putative mechanism of lymphopenia in COVID-19 patients
por: Wang, Xinling, et al.
Publicado: (2022)

S373P Mutation Stabilizes the Receptor-Binding Domain of the Spike Protein in Omicron and Promotes Binding
por: Zheng, Bin, et al.
Publicado: (2023)

Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models
por: Cutone, Antimo, et al.
Publicado: (2022)

Anti-Entry Activity of Natural Flavonoids against SARS-CoV-2 by Targeting Spike RBD
por: Meng, Jie-Ru, et al.
Publicado: (2023)

Cell entry by SARS-CoV-2
por: Peng, Ruchao, et al.
Publicado: (2021)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Dysregulation of T Lymphocyte Proliferative Responses in Autoimmunity
por: Elizer, Sydney K., et al.
Publicado: (2014)

A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2
por: Luan, Junwen, et al.
Publicado: (2020)

Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
por: Zhou, Hao, et al.
Publicado: (2022)

Lipid rafts are involved in SARS-CoV entry into Vero E6 cells
por: Lu, Yanning, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_nkspj44bobfoen63iivfsbv47v